Search results
Showing 1 to 4 of 4 results for bupivacaine
Liposomal bupivacaine for treating postoperative pain [ID3799]
Topic prioritisation
Bupivacaine–meloxicam for treating postoperative pain [ID2728]
Awaiting development Reference number: GID-TA10716 Expected publication date: TBC
This guideline covers the care of pregnant women and pregnant trans and non-binary people and their babies during labour and immediately after birth. It focuses on women and pregnant people who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women and pregnant people to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.
View recommendations for NG235Show all sections
Sections for NG235
- Overview
- Recommendations
- Recommendations for research
- Rationale and impact
- Context
- Appendix A: Adverse outcomes for different places of birth
- Appendix B: Outcomes for different places of birth – by BMI at booking
- Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
NICE has developed a medtech innovation briefing (MIB) on the Epidrum for aiding access to the epidural space